Editas Medicine is a biotechnology company focused on developing transformative therapies using CRISPR gene-editing technology. Founded in 2013, it aims to treat a range of genetic diseases by precisely altering DNA within patients' cells. The company is working on various programs, including treatments for inherited retinal diseases and blood disorders. Editas collaborates with other organizations to advance its research and bring innovative solutions to patients suffering from genetic conditions.